Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
06 Apr 2022 |
AP02 |
Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 6 April 2022
|
|
|
09 Mar 2022 |
TM01 |
Termination of appointment of John Michael Sadler as a director on 4 March 2022
|
|
|
09 Mar 2022 |
AP01 |
Appointment of Mr Khalid El Ansari as a director on 4 March 2022
|
|
|
09 Mar 2022 |
AP01 |
Appointment of Mr David Christopher Senior as a director on 4 March 2022
|
|
|
31 Dec 2021 |
PSC02 |
Notification of Glaxosmithkline Consumer Healthcare Holdings (No.2) Limited as a person with significant control on 22 November 2021
|
|
|
31 Dec 2021 |
PSC07 |
Cessation of Consumer Healthcare Holdings Limited as a person with significant control on 22 November 2021
|
|
|
31 Dec 2021 |
PSC07 |
Cessation of Consumer Healthcare Intermediate Holdings Limited as a person with significant control on 22 November 2021
|
|
|
31 Dec 2021 |
PSC02 |
Notification of Consumer Healthcare Holdings Limited as a person with significant control on 22 November 2021
|
|
|
31 Dec 2021 |
PSC07 |
Cessation of Gsk Consumer Healthcare Holdings (No.7) Limited as a person with significant control on 22 November 2021
|
|
|
31 Dec 2021 |
PSC02 |
Notification of Consumer Healthcare Intermediate Holdings Limited as a person with significant control on 22 November 2021
|
|
|
31 Dec 2021 |
PSC02 |
Notification of Gsk Consumer Healthcare Holdings (No.7) Limited as a person with significant control on 22 November 2021
|
|
|
31 Dec 2021 |
PSC07 |
Cessation of Gsk Consumer Healthcare Holdings (No.5) Limited as a person with significant control on 22 November 2021
|
|
|
19 Nov 2021 |
SH19 |
Statement of capital on 19 November 2021
|
|
|
19 Nov 2021 |
SH20 |
Statement by Directors
|
|
|
19 Nov 2021 |
CAP-SS |
Solvency Statement dated 18/11/21
|
|
|
19 Nov 2021 |
RESOLUTIONS |
Resolutions
-
RES13 ‐
Reduction of share premuim account 18/11/2021
-
RES06 ‐
Resolution of reduction in issued share capital
|
|
|
11 Nov 2021 |
RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 1 September 2021
|
|
|
19 Oct 2021 |
MA |
Memorandum and Articles of Association
|
|
|
11 Oct 2021 |
SH01 |
Statement of capital following an allotment of shares on 1 September 2021
-
ANNOTATION
Clarification a second filed SH01 was registered on 11/11/2021.
|
|
|
08 Sep 2021 |
RESOLUTIONS |
Resolutions
-
RES01 ‐
Resolution of alteration of Articles of Association
|
|
|
10 Aug 2021 |
PSC02 |
Notification of Gsk Consumer Healthcare Holdings (No.5) Limited as a person with significant control on 28 June 2021
|
|
|
10 Aug 2021 |
PSC07 |
Cessation of Prism Pch Limited as a person with significant control on 28 June 2021
|
|
|
15 Jun 2021 |
AA01 |
Current accounting period shortened from 31 May 2022 to 31 December 2021
|
|
|
10 Jun 2021 |
AD01 |
Registered office address changed from 980 Great West Road Brentford Middlesex TW8 2GS United Kingdom to 980 Great West Road Brentford TW8 9GS on 10 June 2021
|
|
|
04 Jun 2021 |
SH01 |
Statement of capital following an allotment of shares on 28 May 2021
|
|